What is Catalent Price-to-Operating-Cash-Flow?
As of today (2024-04-29), Catalent's share price is $56.21.
Catalent's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.94. Hence, Catalent's Price-to-Operating-Cash-Flow Ratio for today is 59.86.
The historical rank and industry rank for Catalent's Price-to-Operating-Cash-Flow or its related term are showing as below:
CTLT'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.27 Med: 26.04 Max: 93.74
Current: 59.85
During the past 13 years, Catalent's highest Price-to-Operating-Cash-Flow Ratio was 93.74. The lowest was 11.27. And the median was 26.04.
Catalent's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.62.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.94.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Catalent was -48.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -21.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.90% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.60% per year.
During the past 13 years, Catalent's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.70% per year. The lowest was -21.50% per year. And the median was 12.20% per year.
Catalent Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Catalent's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catalent Price-to-Operating-Cash-Flow Chart
|
Catalent Annual Data
|
|
Trend |
Jun14 |
Jun15 |
Jun16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
31.91 |
25.32 |
42.45 |
43.51 |
30.91 |
|
Catalent Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
24.77 |
93.74 |
30.91 |
30.23 |
47.85 |
Competitive Comparison of Catalent's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Catalent's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catalent's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Catalent's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Catalent's Price-to-Operating-Cash-Flow falls into.
Catalent Price-to-Operating-Cash-Flow Calculation
Catalent's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 56.21 | / | 0.939 |
| = | 59.86 |
Catalent's Share Price of today is $56.21.
Catalent's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.94.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Catalent (Catalent) Business Description
Traded in Other Exchanges
Address
14 Schoolhouse Road, Somerset, NJ, USA, 08873
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Executives
| David Mcerlane |
officer: Group President, Biologics |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Steven Barg |
director |
ELLIOTT MANAGEMENT CORPORATION, 40 WEST 57TH STREET, NEW YORK NY 10019 |
| Michelle R Ryan |
director |
214 PARK BLVD S, VENICE FL 34285 |
| John J Greisch |
director |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Stephanie Okey |
director |
C/O ALBIREO PHARMA, INC., 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON MA 02109 |
| Frank A Damelio |
director |
C/O PFIZER INC., 235 EAST 42ND ST., NEW YORK NY 10017 |
| Aristippos Gennadios |
officer: See Remarks |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Thomas W Hawkeswood |
officer: Pres. Pharma Prod Delivery Div |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Patricia Hunt |
officer: Pres. Consumer Health Div |
C/O CATALENT, 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Ricky Hopson |
officer: VP, Chief Accounting Officer |
CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Lorenzo Carletti |
officer: SVP Global Ops Small Molecule |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Ricardo Pravda |
officer: SVP, Human Resources |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Alessandro Maselli |
officer: See remarks |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Charles Lickfold |
officer: SVP, CIO |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
| Scott Gunther |
officer: See Remarks |
C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
Catalent (Catalent) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CTLT has been successfully added to your